Reuters logo
a month ago
BRIEF-Bayer says Xarelto in combination with single antiplatelet therapy receives positive CHMP opinion
July 21, 2017 / 12:35 PM / a month ago

BRIEF-Bayer says Xarelto in combination with single antiplatelet therapy receives positive CHMP opinion

July 21 (Reuters) - Bayer says

* Xarelto in combination with single antiplatelet therapy receives positive CHMP opinion for treatment of patients with atrial fibrillation requiring oral anticoagulation and undergoing percutaneous coronary intervention with stent placement Source text: bit.ly/2uPQOpZ Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below